Activation of the p38 and JNK/SAPK mitogen-activated protein kinase pathways during apoptosis is mediated by a novel retinoid

Experimental Cell Research

Volumn 247, Issue 1, 1999, Pages 233-240

  Zhang, Yuxiang ^a   Huang, Ying ^b   Rishi, Arun K ^a   Sheikh, M Saeed ^c   Shroot, Braham ^d   Reichert, Uve ^d   Dawson, Marcia ^e   Poirer, Guy ^f   Fontana, Joseph A ^a  

^a WAYNE STATE UNIVERSITY   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d Ctr Intl Rescherches D   (France)

^e SRI INTERNATIONAL   (United States)

^f UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2 NAPHTHOIC ACID DERIVATIVE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CASPASE; CYCLOHEXIMIDE; DACTINOMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN SERINE THREONINE KINASE; RETINOIC ACID; RETINOID; STRESS ACTIVATED PROTEIN KINASE;

APOPTOSIS; ARTICLE; CELL STRAIN HL 60; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME DEGRADATION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RNA TRANSCRIPTION;

EID: 0033602027     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1998.4350     Document Type: Article

References (51)

1. Giguere V. Retinoic acid receptors and cellular retinoid binding proteins: Complex interplay in retinoid signalling. Endocr. Rev. 15:1994;61-79.
2. Giguere V., Ong S., Segui P., Evans R. Identification of a receptor for the morphogen retinoic acid. Nature. 330:1987;624-627.
3. Petkovich M., Brand N. J., Krust A., Chambon P. A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature. 330:1987;444-445.
4. Brand N., Petrovich A., Krust A., Chanbon P., de The H., Marchio A., Tiollins P., Dejean A. Identification of a second human retinoic acid receptor. Nature. 332:1988;850-853.
5. Benbrook D., Lernhardt E., Pfahl M. A new retinoic acid receptor identified from a hepatocellular carcinoma. Nature. 33:1988;669-672.
6. Krust A., Kastner P., Petkovich M., Zelent A., Chambon P. A third human retinoic acid receptor, hRAR-γ Proc. Natl. Acad. Sci. USA. 86:1989;5310-5314.
7. Ishikawa T., Umesono K., Mangelsdorf D. J., Aburatani H., Stanger B. Z., Shibasaki Y., Imawari M., Evans R. M., Tanaku F. A functional retinoic acid receptor encoded by the gene on human chromosome 12. Mol. Endocrinol. 4:1990;837-844.
8. Hamada K., Gleason S. L., Levi B-Z., Hirschfield S., Appella E., Ozato K. H-2 RII BP, a member of the nuclear hormone receptor super family that binds to both regulatory element of major histocompatibility class I genes and estrogen response element. Proc. Natl. Acad. Sci. USA. 86:1989;8289-8293.
9. Mangelsdorf D. J., Borgmeyer U., Heyman R. A., Zhou J. Y., Ong E. S., Oro A. E., Kakizuka A., Evans R. M. Characterization of three RXR genes that mediate the action of 9-cis-retinoic acid. Genes Dev. 6:1992;329-344.
10. Leid M., Kastner P., Lyons R., Nakshari H., Saunders M., Zacharewski T., Chen J-Y., Staub A., Garnier J. M., Mader S., Chambon P. Purification cloning and RXR identity of the Hela cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently. Cell. 68:1992;377-385.
11. Zhang X-K., Hoffman B., Tran P. B-V., Graupner G., Pfahlm M. Retinoid X receptor is an auxillary protein for thyroid hormone and retinoic acid receptors. Nature. 355:1992;441-446.
12. 3. Nature. 355:1992;446-449.
13. Pfahl M. Nuclear receptor/AP-1 interaction. Endocr. Rev. 14:1993;651-658.
14. Kamei Y., Xu L., Heinzel T., Torchia J., Kurokawa R., Gloss B., Lin S-C., Heyman R. A., Rose D. W., Glass C. K., Rosenfeld M. G. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell. 85:1996;403-414.
15. Wan H., Dawson M. I., Hong W. K., Lotan R. Enhancement of Calu-1 human lung carcinoma cell growth in serum-free medium by retinoids: Dependence on AP-1 activation but not on retinoid element activation. Oncogene. 15:1997;2109-2118.
16. Kalemkerian G. P., Slusher R., Sakkaraiappan R., Gadgeel S., Mabry M. Growth inhibition and induction of apoptosis by fenretinide in small-cell lung cancer cell lines. J. Natl. Cancer Inst. 87:1993;1674-1678.
17. Delia D., Aiello A., Lombardi L., Pelicci P. G., Grignani F., Formelli F., Menard S., Costa A., Veronesi V., Pierotti M. A. N. Cancer Res. 53:1993;6036-6041.
18. Sheikh M. S., Shao Z. M., Li X. S., Ordonez J. V., Conley B. A., Wu S., Dawson M. I., Han Q. X., Chao W. R., Quick T., Fontana J. A. N. Carcinogenesis. 16:1995;2477-2486.
19. Fanjul A. N., Delia D., Perotti M. A., Rideout D., Qiu J., Pfahl M. 4-Hydroxyphenyl retinamide is a highly selective activator of retinoid receptors. J. Biol. Chem. 271:1996;22441-22446.
20. Oridate N., Suzuki S., Higuchi M., Mitchell M. F., Hung W. H., Lotan R. Involvement of reactive oxygen species inN. J. Natl. Cancer Inst. 89:1997;1191-1198.
21. 1o. Oncogene. 11:1995;493-504.
22. Hsu K. A., Rishi A. K., Li A. S., Dawson M. I., Reichert V., Shroot B., Poirer G. C., Fontana J. A. Retinoid induced apoptosis in leukemia cells through a retinoic acid nuclear receptor independent pathway. Blood. 89:1997;4470-4479.
23. Gjertsen B. T., Doskeland S. O. Protein phosphorylation in apoptosis. Biochem. Biophys. Acta. 1269:1995;187-199.
24. Kaufmann, S. H. Desnoyers, S. Ottavino, Y. Davidson, N. E. Poirer, G. G. 1993, Specific proteolytic cleavage of poly (ADP-ribose) polymerase: An early marker of chemotherapy-induced apoptosis, Cancer Res. 53, 3976.
25. Charpentier, B. Bernardon, J. M. Eustach, J. Millois, C. Martin, B. Michel, S. Shroot, B. 1995, Synthesis, structure affinity relationships and biological activities of ligands binding to retinoic acid receptor subtypes, J. Med. Chem. 38, 4993.
26. Sheikh M. S., Li X-S., Chen J. C., Shao Z. M., Ordonez J. V., Fontana J. A. Mechanism of regulation of WAF1/CIPI gene expression in human breast carcinoma. Role of p53-dependent and independent signal transduction pathways. Oncogene. 9:1994;3407-3415.
27. Whitacre C. M., Hashimato H., Tsai M. L., Chattersee S., Berger S. J., Berger N. A. Involvement of NAD poly (ADP-ribose) metabolism in p53 regulation and its consequences. Cancer Res. 55:1995;3697.
28. Itoh N., Yonehara S., Ishii A., Yonehara M., Mizushima S. I., Sameshima M., Hase A., Seto Y., Nagaia S. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell. 66:1991;233-243.
29. Yonehara S., Ishii A., Yonehara M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. Exp. Med. 169:1989;1747-1756.
30. Juo P., Kuo C. J., Reynolds S. E., Konz R. F., Raingeaud J., Davis R. J., Biemann H-P., Blenis J. Fas activation of the p38 mitogen-activated protein kinase signaling pathway requires ICE/CED-3 family proteases. Mol. Cell Biol. 17:1997;24-35.
31. Cuenda A., Rouse J., Doza Y. N., Meier R., Cohen P., Gallagher T. F., Young P. R., Lee J. C. SB203580 is a specific inhibitor of a map kinase homologue which is stimulated by cellular stress and interleukin-1. FEBS Lett. 364:1993;229-233.
32. Lee J. C., Laydon J. T., McDonnel P. C., Gallagher T. F., Kumar S., Green D., McNulty D., Blumenthal M. J., Heys J. R., Landvatter S. W., Strickler J. R., McLaughlin M. M., Siemens I. R., Fisher S. M., Livi G. P., White J. R., Adams J. L., Young P. R. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature. 372:1994;739-746.
33. Pumiglia K. M., Decker S. J. Cell cycle arrest mediated by the MLK/mitogen-activated protein kinase pathway. Proc. Natl. Acad. Sci. USA. 94:1997;448-496.
34. Derijard B., Hi bi M., Wu I-H., Barrett T., Su B., Deng T., Karin M., Davis R. J. JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylases the c-Jun activation domain. Cell. 76:1994;1025-1037.
35. Smeal T., Binetroy B., Mercola D. A., Birrer M., Karin M. Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73. Nature. 354:1991;494-496.
36. Pulverer B. J., Kyriakis J. M., Auruch J., Nikolakaki E., Woodgett J. R. Phosphorylation of c-Jun mediated by MAP kinases. Nature. 353:1991;670-674.
37. Raingeaud J., Whitmarsh A. J., Barrett T., Derijard B., Davis R. J. MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen activated protein kinase signal transduction pathway. Mol. Cell Biol. 16:1996;1247-1253.
38. Han J., Lee J. D., Bibbs L., Ulevitch R. J. A map kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science. 265:1994;808-811.
39. Galcheva-Gargova Z., Derijard B., Wu I-H., Davis R. T. An osmosensing signal transduction pathway in mammalian cells. Science. 265:1994;806-808.
40. Graves J. D., Draves K. E., Craxton A., Saklatvala J., Krebs E. G., Clark E. A. Involvement of stress-activated protein kinase and p38 mitogen-activated protein kinase in mIgM-induced apoptosis of human B lymphocytes. Proc. Natl. Acad. Sci. USA. 93:1991;13814-13818.
41. Derijard B. J., Raingeaud J., Barrett T., Wu I-H., Han J., Ulevitch R. J., Davis R. J. Independent human MAP kinase signal transduction pathways defined by MEK and MKK isoforms. Science. 267:1995;682-685.
42. 1. J. Biol. Chem. 270:1995;7420-7426.
43. Xia Z., Dickens M., Raingeaud J., Davis R. J., Greenberg M. E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science. 270:1995;1326-1331.
44. Lenczowski J. M., Dominquez L., Eder A. M., King L. B., Zacharchuk C. M., Ashwell J. D. Lack of a role for JUN kinase and AP-1 in fas-induced apoptosis. Mol. Cell Biol. 17:1997;170-181.
45. Graves J. D., Draves K. E., Craxton A., Krebs K. G., Clark E. A. A comparison of signaling requirements for apoptosis of human B lymphocytes induced by the B cell receptor. J. Immunol. 161:1998;168-174.
46. Zhang L. X., Mills K. J., Dawson M. I., Collins S. J., Jetten A. M. Evidence for the involvement of RA receptor RARα-dependent signalling pathway in the induction of tissue transglutaminase and apoptosis by retinoids. J. Biol. Chem. 270:1995;6022-6029.
47. Seewaldt V. L., Johnson B. S., Parker M. B., Collins S. J., Swisshelm K. Expression of RA receptor beta mediates RA-induced growth arrest and apoptosis in breast cancer cells. Cell Growth Differ. 6:1995;1077-1088.
48. Liu Y., Lee M-O., Wang H-G., Li Y., Hashimoto Y., Klaus M., Reed J. C., Zhang X. RAR β mediates the growth inhibitory effect of retinoic acid by inducing cell apoptosis in human breast cancer cells. Mol. Cell Biol. 16:1996;1138.
49. Collins S. J., Robertson K. A., Mueller L. RA-induced granulocytic differentiation of HL-60 myeloid leukemia cells is mediated directly through the RA receptor (RAR-α). Mol. Cell. Biol. 10:1990;2154-2163.
50. Nagi L., Thomazy V. A., Shipley G. L., Fesus L., Lamph W., Heyman R. A., Chandraraina R. A., Davis P. J. Activation of retinoid X receptors induces apoptosis in HL-60 cell lines. Mol. Cell. Biol. 15:1995;3540-3551.
51. Liu Z., Hsu H., Goeddel D. V., Karin M. Dissection of TNF receptor effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell. 87:1996;565-576.